April 23
2021
Juan Jonás
share
26th March 2021
Competition & State Aid

Acquisition of joint control of Cytel by Astor and Nordic Capital: approval decision published

Official publication has been made of the European Commission’s decision of 16 February 2021 approving, under Article 6(1)(b) of the EU Merger Regulation, the acquisition of joint control of Cytel Inc. (US-based provider of software and services to the pharmaceutical and biotechnology industry, offering statistical study design software, data science analytics services and consulting, to improve clinical trial outcomes).

The acquiring companies are:

Astorg VII SLP, of Luxembourg (private equity group); and Nordic Capital X Limited (Jersey-based group of private equity funds investing across a wide array of industries). 

The Commission concluded that the proposed acquisition would raise no competition concerns, given that

×

Your privacy is important for us

We use cookies to improve the user experience. Please review privacy preferences.

Accept all Settings

Check our privacy policy and cookies policy.

Cookies